6.21 -0.07 (-1.11%)
TRGT
| Trade TRGT now with |
|
Stock Details
Last Trade:6.21 Change:-0.07 (-1.11%) Prev Close:6.28 Open: 6.30 Days Range:6.19 – 6.38 52 Week Range: 4.91 - 30.47 Volume:235012 P/E: 17.74EPS:0.35
View AllRecent Alerts 02/10/12
Recent Alert on 01/06/12 at 10:58am
Needham & Company Maintains a 'Hold' on Targacept (TRGT); Sidelined Until TC5214 Phase 3 Story in Depression is Fully Resolved
Needham & Company Maintains a 'Hold' on Targacept (TRGT); Sidelined Until TC5214 Phase 3 Story in Depression is Fully Resolved
Needham & Company maintains a 'Hold' on Targacept (NASDAQ: TRGT). Needham analyst says, "Targacept and collaborator AstraZeneca (NYSE: AZN)(NR) are expected to announce results from remaining Phase 3 trials of TC-5214 in depression in 1H12. The... Read More
Recent Alert on 01/05/12 at 8:56am
Targacept (TRGT) Says AstraZeneca (AZN) to Progress AZD1446 Development
Targacept (TRGT) Says AstraZeneca (AZN) to Progress AZD1446 Development
Recent Alert on 01/05/12 at 8:56am
Targacept (TRGT) Says AstraZeneca (AZN) to Progress AZD1446 Development
Targacept (TRGT) Says AstraZeneca (AZN) to Progress AZD1446 Development
Recent Alert on 12/28/11 at 7:42am
Short Interest Ticks Up in Large-Cap Biotech, Specifically Amgen (AMGN)
Short Interest Ticks Up in Large-Cap Biotech, Specifically Amgen (AMGN)
Recent Alert on 12/28/11 at 7:42am
Short Interest Ticks Up in Large-Cap Biotech, Specifically Amgen (AMGN)
Short Interest Ticks Up in Large-Cap Biotech, Specifically Amgen (AMGN)
View AllRecent Press Releases
Press Release on 02/07/12 at 8:55am
Targacept to Report Fourth Quarter and 2011 Financial Results on February 21, 2012
Targacept to Report Fourth Quarter and 2011 Financial Results on February 21, 2012